Targeted Therapies and Survival: What We Can Learn from Studies in Advanced Renal Cell Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|84|1|39-42

ISSN： 0030-2414

Source： Oncology, Vol.84, Iss.1, 2012-10, pp. : 39-42

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

What can we learn from variation of red cell size distribution?

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 5, 2015-05 ,pp. : 369-370

John Wiley & Sons Inc

Access to resources Recommend Favorite

Racial disparities in survival among patients with advanced renal cell carcinoma in the targeted therapy era

By  

CANCER, Vol. 122, Iss. 19, 2016-10 ,pp. : 2988-2995

John Wiley & Sons Inc

Access to resources Recommend Favorite

Application of hepatocellular carcinoma surveillance in a European setting. What can we learn from clinical practice?

By  

LIVER INTERNATIONAL (ELECTRONIC), Vol. 35, Iss. 7, 2015-07 ,pp. : 1862-1871

John Wiley & Sons Inc

Access to resources Recommend Favorite

The rural–urban enigma of allergy: What can we learn from studies around the world?

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 26, Iss. 2, 2015-03 ,pp. : 95-102

John Wiley & Sons Inc

Access to resources Recommend Favorite

Time from Nephrectomy as a Prognostic Factor in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapies: Overall Results from a Large Cohort of Patients

By  

Oncology, Vol. 88, Iss. 3, 2014-11 ,pp. : 133-138

Karger

Access to resources Recommend Favorite